Study shows Omicron greatly reduces Covid antibody protection
December 9, 2021: -South African scientists say the Covid omicron variant significantly reduces antibody protection generated by Pfizer and BioNTech’s vaccine. However, according to a small preliminary study released Tuesday, people who have recovered from the virus and received booster doses will likely have protection from severe disease.
Sanofi is ditching the mRNA Covid-19 vaccine after rivals’ success
September 29, 2021: -On Tuesday, Sanofi is dropping plans for its mRNA-based Covid-19 vaccine because of the dominance achieved by BioNTech-Pfizer, and Moderna uses the technology to fight the pandemic, the company said.
Robotic surgery is the healthcare future. Activ Surgical raises $15 million
July 17, 2020: The Boston based startup is a pioneer in advanced technology for the Healthcare Industry. Every healthcare professional cannot expertise in everything they do at work.
Pfizer’s CEO sees a return to ‘normal’ globally by the end of 2022
June 18, 2021: Pfizer CEO Albert Bourla told CNBC that he expects life to return to normal for developed countries by this year’s end and the rest of the world by the end of 2022.
Pfizer says the Covid vaccine is 100% effective in kids ages 12 to 15
April 01 2021:-On Wednesday, Pfizer said its Covid-19 vaccine was robustly effective in kids, demonstrating 100% efficacy in phase three clinical trial testing its shot in adolescents aged 12 to 15.
Pfizer says Israel data shows the third Covid shot restores protection
September 17, 2021: -According to data submitted to the Food and Drug Administration, a third dose of Pfizer’s Covid vaccine six months after a second dose gives 95% protection from infection in a world set in Israel.
Pfizer plans to file for full FDA approval of the Covid vaccine
May 5, 2021: -On Tuesday, Pfizer said it plans to file for full U.S. approval of its Covid-19 vaccine with German drugmaker BioNTech at this month-end. The company will be able to market the shot directly to consumers if the company signs off.
Pfizer CEO warns of the early need for fourth Covid dose
December 10, 2021: -Pfizer CEO Albert Bourla said Wednesday that people might need a fourth Covid-19 shot sooner than expected after preliminary research shows the new omicron variant can undermine protective antibodies generated by the vaccine the company developed with BioNTech.
Pfizer and BioNTech Covid vaccine scientist recommend the third shot
April 23, 2021: -On Wednesday, the chief medical officer of BioNTech told CNBC that people would likely need a third dose of its two-dose Covid-19 vaccine as immunity against the virus wanes, agreeing with previous comments made by Pfizer CEO Albert Bourla.
Omicron will challenge Hong Kong’s zero-Covid policy
January 17, 2022: -The highly transmissible omicron variant will be a “tough challenge” for Hong Kong as the city sticks to its zero-Covid policy, a former U.S. diplomat told CNBC.
